BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18333895)

  • 1. Squamous cell carcinomas with single cell infiltration: a potential diagnostic pitfall and the utility of MNF116 and p63.
    Ko CJ; McNiff JM; Glusac EJ
    J Cutan Pathol; 2008 Apr; 35(4):353-7. PubMed ID: 18333895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
    Dotto JE; Glusac EJ
    J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
    Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
    Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
    Alomari AK; Glusac EJ; McNiff JM
    J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
    Kaufmann O; Fietze E; Mengs J; Dietel M
    Am J Clin Pathol; 2001 Dec; 116(6):823-30. PubMed ID: 11764070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
    Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
    Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
    Wagoner J; Keehn C; Morgan MB
    Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.
    Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW
    J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants.
    Mitsuhashi T; Itoh T; Shimizu Y; Ban S; Ogawa F; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Mar; 33(3):246-52. PubMed ID: 16466514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
    Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
    Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratin Expression Patterns in Stromal Cells of Benign Sclerosing Lesions of the Breast: A Potential Diagnostic Pitfall.
    Oh EY; Collins LC
    Arch Pathol Lab Med; 2015 Sep; 139(9):1143-8. PubMed ID: 25989286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63 as a complimentary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions.
    Shiran MS; Tan GC; Sabariah AR; Rampal L; Phang KS
    Med J Malaysia; 2007 Mar; 62(1):36-9. PubMed ID: 17682568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast-like giant cell reaction associated with cutaneous squamous cell carcinoma: a report of 2 cases and review of the literature.
    Wooff J; Werner D; Murphy J; Walsh N
    Am J Dermatopathol; 2009 May; 31(3):282-7. PubMed ID: 19384071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.